Tibet Rhodiola Pharmaceutical Holding

Tibet Rhodiola Pharmaceutical Holding Dividend Coverage

The Dividend Coverage Ratio of Tibet Rhodiola Pharmaceutical Holding (600211.SS) as of Oct 19, 2026 is 1.56. In the previous year, Dividend Coverage Ratio was 2.11 — a change of -26.42% (lower).

Dividend Coverage

1.56

YoY

-26.42%

Last updated:

Dividend Coverage Ratio of Tibet Rhodiola Pharmaceutical Holding is 2025 1.56 . Dividend Coverage Ratio of Tibet Rhodiola Pharmaceutical Holding was 2024 2.11 . It decreases by -26.42% lower compared to the previous year.

The Tibet Rhodiola Pharmaceutical Holding Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2018
3.11 CNY
Jan 1, 2019
4.62 CNY
Jan 1, 2020
1.62 CNY
Jan 1, 2021
1.63 CNY
Jan 1, 2022
4.36 CNY
Jan 1, 2023
1.65 CNY
Jan 1, 2024
2.11 CNY
Jan 1, 2025
1.56 CNY
The Tibet Rhodiola Pharmaceutical Holding Dividend Coverage history
YEARDividend CoverageYoY
1.56-26.42%
2.11+27.93%
1.65-62.14%
4.36+168.46%
1.63+0.29%
1.62-64.93%
4.62+48.44%
3.11-19.30%
3.86-45.97%
7.14-43.95%
12.74+418.75%
2.46—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tibet Rhodiola Pharmaceutical Holding Stock analysis

What does Tibet Rhodiola Pharmaceutical Holding do? Tibet Rhodiola Pharmaceutical Holding Co, listed on the Shanghai Stock Exchange under ticker 600211.SS, operates as a pharmaceutical company based in Lhasa, China. The company's ISIN is CNE000000ZW7. Founded through an IPO on July 21, 1999, it specializes in the manufacture and wholesale of pharmaceutical products. Its headquarters are located in Lhasa, Xizang, and it employs 615 full-time staff. The firm distributes proprietary drug products and processes pharmaceuticals, conducting business primarily across South China, North China, East China, Central China, and overseas markets. The company's website is http://www.xzyy.cn. It does not provide details on specific products, acquisitions, or financial figures beyond the IPO date and employee count. The company focuses on pharmaceutical manufacturing and distribution within its operational regions, with no additional information provided on its product lines or market share. Tibet Rhodiola Pharmaceutical Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tibet Rhodiola Pharmaceutical Holding stock

Dividend Coverage Ratio of Tibet Rhodiola Pharmaceutical Holding is 1.56 in 2025.

Dividend Coverage Ratio of Tibet Rhodiola Pharmaceutical Holding changed from 2.11 to 1.56, representing a -26.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Tibet Rhodiola Pharmaceutical Holding since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Tibet Rhodiola Pharmaceutical Holding historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — Tibet Rhodiola Pharmaceutical Holding

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — Tibet Rhodiola Pharmaceutical Holding